About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Novel Biomarkers, Therapeutic Targets for Prevention and Treatment of Cardiovascular Diseases

by Iswarya on December 27, 2018 at 2:51 PM
Font : A-A+

Novel Biomarkers, Therapeutic Targets for Prevention and Treatment of Cardiovascular Diseases

New study finds that metabolomic biomarkers can help clinicians to identify cardiovascular disease risk and take preventive steps before the disease can surface. The findings of the study are published in the journal Cardiovascular & Hematological Disorders-Drug Targets.

Cardiovascular diseases (CVDs) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

Advertisement


Efforts to prevent CVD have little effect on the decrease in the number of CVD related deaths despite many medical advances.

Therefore, the search for new and even better therapies and treatments for the betterment of those who are suffering from CVD is still in progress.
Advertisement

The field of metabolomics has offered a good solution to these diseases. Metabolomic biomarkers help clinicians to identify the risk of CVD and take preventive measures before the diseases can surface. Early diagnosis of CVD is a good sign for a patient's recovery and also for their health. Therefore, there is a need to establish reliable, sensitive and non-invasive biomarkers which can serve as therapeutic targets for the prevention and treatment of CVD.

In this study, analytical techniques are discussed along with the workflow that is used in untargeted metabolomics. Case studies that highlight the use of untargeted metabolomics in CVD research are also identified. Five of the case studies show approaches to identify untargeted metabolomics and apply this information in clinical situations. The analysis was conducted for the prediction of cardiovascular disease risk, myocardial ischemia, transient ischemic attack, incident coronary heart disease, and myocardial infarction risk.

The use of the untargeted metabolomics for risk assessment is still relatively new, and there is still a need for future advancements in metabolomics technologies.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
Emotional Healing
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Atherosclerosis 

Recommended Reading
Congenital Heart Disease
Heart diseases that are present at birth are called " Congenital heart diseases"....
Diet, Lifestyle and Heart Disease
The correlation between diet, lifestyle and heart disease. The importance of balanced diet life ......
Lifestyle Paths to Prevent Heart Disease
Heart disease can be of many types depending upon whether they involve the heart muscles or artery ....
Rheumatic Heart Disease (RHD)
Rheumatic heart disease is a sequelae of rheumatic fever that affects heart valves. Rheumatic fever ...
Atherosclerosis
Atherosclerosis is a condition in which the arteries become hard and narrow, leading to restricted b...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use